PeptidePedia The community reference

Talk:Receptor bias

Discussion page·2 threads·no archives

This article is within the scope of the pharmacology working group.

This is the discussion page for the article Receptor bias. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Productive research, disappointing translationResolved

That summary is fair and is the one a reader needs, because bias claims appear in promotional material far more often than in outcome data. GsCouplingGil (talk) 09:40, 27 February 2026 (UTC)

And the three questions at the end give a reader something to do with such a claim. ✓ Done PuffRemoverPax (talk) 13:15, 27 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Two senses of biasDone

Potency imbalance between two receptors and signalling preference at one receptor are different things called the same word. Separating them here helps the tirzepatide article. ReceptorRhoda (talk) 10:30, 25 May 2026 (UTC)

Cross-linked in both directions. ✓ Done TirzTaxonomist (talk) 14:05, 25 May 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 25 May 2026, by TirzTaxonomist. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).